Adcendo ApS
9 known investors
Adcendo develops antibody-drug conjugates (ADCs) targeting cancers with high unmet medical need. The company engineers therapeutic medicines designed to deliver clinically differentiated outcomes for cancer patients.
Investors · 9
Competitors · 1
by search overlapCompanies competing with Adcendo ApS for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Venture funding drops in Seattle area as AI boom reshapes startup world – GeekWiregeekwire.com · Jul 2026Frequently asked questions
- What does Adcendo ApS do?
- Adcendo develops antibody-drug conjugates (ADCs) targeting cancers with high unmet medical need. The company engineers therapeutic medicines designed to deliver clinically differentiated outcomes for cancer patients.
- Who are Adcendo ApS's investors?
- Adcendo ApS's investors include Vida Ventures, HealthCap, Jeito Capital, Novo Holdings, OrbiMed, Pontifax Venture Capital, RA Capital, TCG Crossover and 1 more.
